Low-Dose Oral Minoxidil and Topical Minoxidil: Consensus Recommendations for Managing Male and Female Pattern Hair Loss in Hair Transplant Patients Using a Modified Delphi Process

    Aditya K. Gupta, Mesbah Talukder, Greg Williams, Haitham Abdelhamid, Yagiz Matthew Akiska, David M. Alpeter, Scott A. Boden, Randa Erfan, Bessam Farjo, Nilofer Farjo, Steven Gabel, James A. Harris, Karl Hekimian, Sharon A. Keene, Jennifer Krejci-Manwaring, Robert T. Leonard, Luis A. Nader, Damkerng Pathomvanich, David Perez-Meza, Nicole E. Rogers, Paul T. Rose, Marie A. Schambach, Ronald Shapiro, Mayank Singh, Dow B. Stough, Robert H. True, Sara M. Wasserbauer, Ryan J. Welter
    TLDR Low-dose oral and topical minoxidil are recommended for managing hair loss in transplant patients, with specific dosing and timing guidelines.
    This study provides consensus-based recommendations for the use of low-dose oral minoxidil (LDOM) and topical minoxidil in managing male and female pattern hair loss, particularly in hair transplant patients. An international panel of hair transplant surgeons used a modified Delphi process to reach consensus on 47 items related to assessment, dosing, monitoring, and safety. Key recommendations include starting LDOM at 1.25–2.5 mg/day for men and 0.625–1.25 mg/day for women, with maximum doses of 5 mg and 2.5 mg, respectively. Clinical improvement is expected within 4–6 months, and treatment can be continued long-term if effective. LDOM can be resumed 1–3 days post-surgery, while topical minoxidil can be applied 7–14 days after transplant. Side effects of LDOM include tachycardia, headache, peripheral edema, and hypertrichosis, which are dose-related and manageable. Topical minoxidil 5% is effective on the frontal scalp and vertex but should be avoided during pregnancy and breastfeeding.
    Discuss this study in the Community →

    Research cited in this study

    38 / 38 results

    Related Community Posts Join

    6 / 1000+ results

      community Being Safe on Oral Minoxidil: tl;dr on the literature.

      in Research/Science  51 upvotes 1 year ago
      Oral minoxidil is effective for hair loss but can cause cardiovascular side effects, such as pericardial effusion, especially in those with genetic predispositions. Starting with low doses and monitoring cardiovascular health are advised to reduce risks.

      community I am a dermatologist with a clinical interest in alopecia. AMA

      in Will treatment work for me? 3 years ago
      In this conversation, 4990 discussed various treatments for hair loss, including oral minoxidil, PRP, transplan, Jak inhibitors, Dutasteride, Finasteride, Olumiant, Ketoconazole, RU58841, microneedling, baricitinib, and CCCA. They recommended scalp biopsies in unclear cases of DUPA, twice weekly to twice daily shampooing for topical minoxidil users, and two sessions spaced one month apart with follow up at month three to determine the effectiveness of PRP treatment.
      21M Concerned About Temple Recession: Minoxidil/Finasteride Worth It?

      community 21M Concerned About Temple Recession: Minoxidil/Finasteride Worth It?

      in General  203 upvotes 2 months ago
      A 21-year-old is experiencing hair loss and is considering using Minoxidil and Finasteride, but is concerned about lifelong dependency and seeks advice on permanent solutions. They are advised to act quickly, consider additional treatments like Dutasteride, and get blood tests to rule out other causes.

    Similar Research

    6 / 1000+ results